Status:
COMPLETED
Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation
Lead Sponsor:
Seoul National University Hospital
Conditions:
Recovery
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
This prospective randomized trial aims to compare recovery time from discontinuation of remimazolam followed by flumazenil administration vs. propofol total intravenous anesthesia as the main general ...
Detailed Description
Adult patients with atrial fibrillation undergoing radiofrequency catheter ablation under general anesthesia are randomized to receive either remimazolam with flumazenil or propofol total intravenous ...
Eligibility Criteria
Inclusion
- Adult patient, age 20-75 years, scheduled for radiofrequency catheter ablation of atrial fibrillation under general anesthesia
Exclusion
- Patients who are not alert before procedure
- Hemodynamicaly unstable patients before procedure
- Patients with history of adverse reaction of allergic reaction to study drugs
- Patients who are anticipated to be unable to remove supraglottic airway or endotracheal tube due to severe dyspnea or need for mechanical ventilatory support
- Use of sedatives (anxiolytics, psychoactive medication, antidepressants, hypnotics) within 24 h
- Known galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption
- Severe hepatic or renal dysfunction
- Alcohol or drug dependence
- Organic brain disorder
- Spinal or cerebellar ataxia
- Acute narrow-angle glaucoma
- Patients with shock or coma
- Pregnant or lactating women
- Patients with hypersensitive to beans or peanut
- Patients who refuse to participate
Key Trial Info
Start Date :
August 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2023
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT05397886
Start Date
August 2 2022
End Date
April 25 2023
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080